QuantuMDx

QuantuMDx is a MedTech startup founded in 2008, aiming to revolutionize the field of molecular diagnostics with its slogan "Transforming Point of Need Multiplex Diagnostics." The company's mission is to empower individuals worldwide by providing access to high-quality, multiplex molecular diagnostic solutions at the point of need. They believe that improved access to testing can significantly enhance the quality of life by reducing time, cost, and anxiety associated with diagnostics, ultimately leading to reduced suffering. QuantuMDx's commitment to addressing real-world problems through innovative solutions has garnered attention in the Biotechnology, Health Care, and Pharmaceutical industries. In a recent development, the company secured a £15.00M Venture Round investment on 08 November 2021 from Vita Spring IVD Fund. This investment is indicative of the confidence that investors have in QuantuMDx's vision and technology. Operating from the United Kingdom, QuantuMDx's focus on enabling access to diagnostics at the point of need demonstrates a commitment to making a global impact. With the support of strategic investors and a compelling vision, QuantuMDx is poised to further establish itself as a leader in transforming diagnostic capabilities, offering potential for significant growth and positive societal impact.